Bio-Techne Releases Second Quarter Fiscal 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Bio-Techne (TECH) Tops Q2 EPS by 8c, Revenues Beat
February 5, 2019 6:34 AM ESTBio-Techne (NASDAQ: TECH) reported Q2 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $174.5 million versus the consensus estimate of $170.19 million.
Second quarter organic revenue increased by 11% (13% reported) to $174.5 million.GAAP EPS was $0.45 vs. $1.29 one year ago. Current Year GAAP EPS saw a one-time benefit for tax reform of $0.02 compared to a prior year GAAP EPS benefit of $0.94. Delivered adjusted earnings per share (EPS) of $1.06, an increase of 4% over the prior year. Excellent commercial execution in all major regions, especially China, with organic growth over... More